MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, GRI had $2,819K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$2,819K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Prepaid expenses and other curre...
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts payable
    • Accrued expenses
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Change in fair value of warrant liability
-0 0 0
Net loss
-1,998 -2,659 -3,359 -5,938
Depreciation expense
1 1 1 2
Stock-based compensation expense
31 67 465 261
Change in operating lease right-of-use assets
13 12 13 23
Prepaid expenses and other current assets
-105 14 -132 -133
Accounts payable
-1,507 272 20 371
Accrued expenses
-317 -638 428 269
Operating lease liabilities
-13 -12 -13 -23
Cash used in operating activities
-3,685 -2,971 -2,313 -4,902
Purchase of property and equipment
-3 --
Cash used in investing activities
--3 --
Proceeds from issuance of common stock in financing transaction / under atm facility-Through Financing
-8,000 0 5,000
Proceeds from issuance of common stock in financing transaction / under atm facility-At The Market Offering
-0 1,619 941
Proceeds from warrant exercise
-0 0 -
Proceeds from issuance of common stock under atm facility
6,819 ---
Payment for fractional shares in connection with reverse stock split
1 0 0 1
Payment of stock issuance costs
314 852 373 944
Cash provided by (used in) financing activities
6,504 7,148 1,246 4,996
Net increase (decrease) in cash and cash equivalents
2,819 4,174 -1,067 94
Cash and cash equivalents at beginning of period
8,229 4,055 5,028 -
Cash and cash equivalents at end of period
11,048 8,229 4,055 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock under atm...$6,819K Cash provided by(used in) financing...$6,504K Canceled cashflow$315K Net increase(decrease) in cash and cash...$2,819K Canceled cashflow$3,685K Payment of stockissuance costs$314K Payment for fractionalshares in connection...$1K Prepaid expenses andother current assets-$105K Stock-based compensationexpense$31K Change in operatinglease right-of-use...$13K Depreciation expense$1K Cash used inoperating activities-$3,685K Canceled cashflow$150K Net loss-$1,998K Accounts payable-$1,507K Accrued expenses-$317K Operating leaseliabilities-$13K

GRI Bio, Inc. (GRI)

GRI Bio, Inc. (GRI)